{
  "ticker": "LLY",
  "target_date": "2025-03-13",
  "actual_date": "2025-03-13",
  "collected_at": "2025-12-08T11:30:51.238560",
  "price": {
    "open": 813.58,
    "high": 816.44,
    "low": 790.85,
    "close": 797.0862426757812,
    "volume": 3566300,
    "change_1d_pct": -2.46,
    "change_7d_pct": -12.01,
    "change_30d_pct": -0.13
  },
  "technicals": {
    "rsi_14": 35.06,
    "sma_20": 872.0,
    "sma_50": 824.01,
    "macd": -0.581,
    "macd_signal": 14.556,
    "macd_histogram": -15.137,
    "bb_upper": 948.63,
    "bb_lower": 795.37,
    "price_vs_sma20_pct": -8.59,
    "price_vs_sma50_pct": -3.27,
    "volume_ratio": 0.97
  },
  "fundamentals": {
    "market_cap": 890826915840,
    "pe_ratio": 48.687893,
    "forward_pe": 43.85348,
    "price_to_book": 37.414154,
    "price_to_sales": 14.992089,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.64,
    "pct_from_52w_low": 59.31
  },
  "macro": {
    "spy": {
      "price": 546.63,
      "change_1d_pct": -1.33,
      "change_7d_pct": -5.43
    },
    "vix": {
      "level": 24.66,
      "signal": "ELEVATED"
    },
    "treasury_10y": {
      "yield_pct": 4.27
    },
    "dollar_index": {
      "level": 103.83
    },
    "gold": {
      "price": 2984.3
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Model Portfolio For Capital Appreciation, March 2025",
      "source": "SeekingAlpha",
      "datetime": 1741891286,
      "summary": "Discover 25 top investment-grade stocks to buy! See strategies to capitalize on market volatility and build a portfolio to outperform the S&P 500. Click for more.",
      "url": "https://finnhub.io/api/news?id=c47684e0abf57aa0f1196923c4819dfa5ebd60823f7eddb83c494e1adc6b4521"
    },
    {
      "headline": "Eli Lilly (NYSE:LLY) Surges 5% Following Breakthrough BRAVE-AA-PEDS Study Results",
      "source": "Yahoo",
      "datetime": 1741887193,
      "summary": "Recent developments at Eli Lilly (NYSE:LLY) have highlighted significant strides in both product innovation and operational expansion. Among the latest announcements, the pharmaceutical giant revealed promising results from its Phase 3 BRAVE-AA-PEDS study, showcasing the efficacy of baricitinib in t",
      "url": "https://finnhub.io/api/news?id=bd9a5996db33e0ab2d1e7044eddabc5d9205b4a95abaab5496a7a5c9df622661"
    },
    {
      "headline": "AbbVie Is Preparing To Challenge Eli Lilly And Novo Nordisk",
      "source": "SeekingAlpha",
      "datetime": 1741881328,
      "summary": "AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.",
      "url": "https://finnhub.io/api/news?id=97963aec81445ff676b23871bfef68c04faaac987c94a9cb5d5b71726d72c61d"
    },
    {
      "headline": "Trump\u2019s $1.4 Trillion Tariff Threat Spurs Companies to Seek Cover",
      "source": "Yahoo",
      "datetime": 1741879184,
      "summary": "(Bloomberg) -- Supply Lines is a daily newsletter that tracks global trade. Sign up here.Most Read from BloombergTrump DEI Purge Hits Affordable Housing GroupsElectric Construction Equipment Promises a Quiet RevolutionNYC Congestion Pricing Toll Gains Support Among City ResidentsOpen Philanthropy La",
      "url": "https://finnhub.io/api/news?id=20bf8bc8457749e1df040a85f0727e9e80883b09dfee00b0510f2d316fd5c69d"
    },
    {
      "headline": "How to Play VKTX Stock Amid Manufacturing Deal With CordenPharma",
      "source": "Yahoo",
      "datetime": 1741875660,
      "summary": "Given the optimism around its obesity candidate, we believe investors should stay invested in Viking Therapeutics.",
      "url": "https://finnhub.io/api/news?id=4732b378a2407a32cb516be67909a4c7b30e571e19fe8725cd90ecc9b5f2773e"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-03-13",
      "description": "xslF345X05/wk-form4_1741897046.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000091/xslF345X05/wk-form4_1741897046.xml"
    },
    {
      "form": "4",
      "date": "2025-03-04",
      "description": "xslF345X05/form4-03042025_040301.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000141588925006450/xslF345X05/form4-03042025_040301.xml"
    },
    {
      "form": "4",
      "date": "2025-03-03",
      "description": "xslF345X05/wk-form4_1741038785.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000083/xslF345X05/wk-form4_1741038785.xml"
    },
    {
      "form": "4",
      "date": "2025-03-03",
      "description": "xslF345X05/wk-form4_1741038712.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000081/xslF345X05/wk-form4_1741038712.xml"
    },
    {
      "form": "4",
      "date": "2025-02-26",
      "description": "xslF345X05/form4-02262025_040201.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000141588925005670/xslF345X05/form4-02262025_040201.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}